Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Non-Resectable Adult Liver Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01425879
What this trial is testing

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00777894
What this trial is testing

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Swiss Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00005629
What this trial is testing

Vaccine Therapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00077142
What this trial is testing

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 37
Large-scale testing (Phase 3)UnknownNCT01324076
What this trial is testing

Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University College, London 412
Testing effectiveness (Phase 2)UnknownNCT00003044
What this trial is testing

Chemotherapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Matrix Pharmaceutical 55
Not applicableApproved For MarketingNCT00906984
What this trial is testing

TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more
University of California, Irvine
Early research (Phase 1)Ended earlyNCT00003147
What this trial is testing

Gene Therapy in Treating Patients With Cancer of The Liver

Who this might be right for
Liver Cancer
National Cancer Institute (NCI) 30
Not applicableEnded earlyNCT03563274
What this trial is testing

QuiremSpheres Observational Study

Who this might be right for
Liver, Cancer of, Non-Resectable
Terumo Europe N.V. 20
Testing effectiveness (Phase 2)Study completedNCT00006010
What this trial is testing

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Alliance for Clinical Trials in Oncology 25
Large-scale testing (Phase 3)Study completedNCT00003424
What this trial is testing

Tamoxifen in Treating Patients With Primary Liver Cancer

Who this might be right for
Liver Cancer
National Medical Research Council (NMRC), Singapore 300
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Not applicableEnded earlyNCT00469963
What this trial is testing

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Vanderbilt-Ingram Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00006006
What this trial is testing

Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

Who this might be right for
Liver Cancer
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT00867321
What this trial is testing

Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Alliance for Clinical Trials in Oncology 24
Not applicableNot Yet RecruitingNCT05750329
What this trial is testing

Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)

Who this might be right for
Liver Transplant DisorderHepatic CancerEnd-stage Liver Disease
RenJi Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00335829
What this trial is testing

Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
Yale University 26
Testing effectiveness (Phase 2)Study completedNCT00095992
What this trial is testing

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
NCIC Clinical Trials Group 15
Not applicableStudy completedNCT01910909
What this trial is testing

Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Samsung Medical Center 56
Not applicableStudy completedNCT01899261
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
Montefiore Medical Center 20
Next Page